Cubist Systematic Strategies, LLC Ideaya Biosciences, Inc. Transaction History

Cubist Systematic Strategies, LLC

$14.3 Billion
Q2 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$34.2 - $47.13 $158,209 - $218,023	4,626 Added 43.6%	15,237 $668,000
Q4 2023 Feb 14, 2024	BUY	$24.59 - $35.83 $260,924 - $380,192	10,611 New	10,611 $377,000
Q1 2023 May 15, 2023	BUY	$13.49 - $18.72 $95,590 - $132,649	7,086 Added 10.61%	73,855 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$14.47 - $18.17 $663,073 - $832,622	45,824 Added 218.78%	66,769 $1.21 Million
Q3 2022 Nov 14, 2022	BUY	$9.24 - $15.79 $131,374 - $224,502	14,218 Added 211.36%	20,945 $312,000
Q2 2022 Aug 15, 2022	SELL	$8.28 - $13.88 $571,129 - $957,400	-68,977 Reduced 91.11%	6,727 $93,000
Q1 2022 May 16, 2022	BUY	$11.18 - $24.02 $832,898 - $1.79 Million	74,499 Added 6182.49%	75,704 $847,000
Q4 2021 Feb 14, 2022	SELL	$20.95 - $26.88 $116,146 - $149,022	-5,544 Reduced 82.15%	1,205 $28,000
Q3 2021 Nov 15, 2021	SELL	$17.26 - $27.08 $20,867 - $32,739	-1,209 Reduced 15.19%	6,749 $172,000
Q2 2021 Aug 16, 2021	SELL	$17.76 - $24.83 $46,957 - $65,650	-2,644 Reduced 24.94%	7,958 $167,000
Q1 2021 May 17, 2021	SELL	$13.48 - $23.77 $17,591 - $31,019	-1,305 Reduced 10.96%	10,602 $249,000
Q4 2020 Feb 16, 2021	SELL	$12.17 - $17.52 $15,930 - $22,933	-1,309 Reduced 9.9%	11,907 $167,000
Q3 2020 Nov 16, 2020	BUY	$11.22 - $14.46 $95,168 - $122,649	8,482 Added 179.17%	13,216 $166,000
Q2 2020 Aug 14, 2020	BUY	$3.59 - $18.57 $16,589 - $85,811	4,621 Added 4089.38%	4,734 $67,000
Q1 2020 May 15, 2020	SELL	$3.03 - $10.58 $3,802 - $13,277	-1,255 Reduced 91.74%	113 $0
Q4 2019 Feb 14, 2020	BUY	$5.34 - $9.09 $5,590 - $9,517	1,047 Added 326.17%	1,368 $10,000
Q3 2019 Nov 14, 2019	SELL	$6.06 - $10.91 $28,166 - $50,709	-4,648 Reduced 93.54%	321 $3,000
Q2 2019 Aug 14, 2019	BUY	$9.58 - $11.95 $47,603 - $59,379	4,969 New	4,969 $49,000

Others Institutions Holding IDYA

# of Institutions

206

Shares Held

73.6M

Call Options Held

21.5K

Put Options Held

20.3K

Black Rock Inc. New York, NY

6.81M
Shares

$216 Million
0.01% of portfolio
Federated Hermes, Inc. Pittsburgh, PA

4.86M
Shares

$154 Million
0.41% of portfolio
Vanguard Group Inc Valley Forge, PA

4.27M
Shares

$135 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.08M
Shares

$129 Million
0.08% of portfolio
Price T Rowe Associates Inc Baltimore, MD

3.74M
Shares

$119 Million
0.02% of portfolio

View Full List

About IDEAYA Biosciences, Inc.

Ticker IDYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,067,700
Market Cap $1.52B
Description
IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...

More about IDYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account